GlyTR Therapeutics is a startup based in the United States.
GlyTR Therapeutics is a company headquartered in the United States.
GlyTR Therapeutics is a biotech company developing a new class of anti-cancer immunotherapeutic molecules and CAR-T cell therapies that target multiple types of cancer antigens across solid and blood cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.